Helius Medical Technologies Files 8-K
Ticker: HSDT · Form: 8-K · Filed: Sep 29, 2025 · CIK: 1610853
| Field | Detail |
|---|---|
| Company | Helius Medical Technologies, Inc. (HSDT) |
| Form Type | 8-K |
| Filed Date | Sep 29, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-statements, filing-update
TL;DR
Helius Medical Tech filed an 8-K on 9/29/25 for corporate updates and financials.
AI Summary
On September 29, 2025, HELIUS MEDICAL TECHNOLOGIES, INC. filed an 8-K report detailing amendments to its Articles of Incorporation or Bylaws, other events, and financial statements. The company, incorporated in Delaware with its fiscal year ending December 31, is involved in the electromedical and electrotherapeutic apparatus industry.
Why It Matters
This filing indicates updates to the company's foundational documents and potentially new financial information, which could impact investors' understanding of its corporate structure and financial health.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for corporate updates and financial statements, not indicating immediate significant operational or financial distress.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- HELIUS MEDICAL TECHNOLOGIES, INC. (company) — Registrant
- September 29, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 36-4787690 (identifier) — IRS Employer Identification Number
- 3845 (industry_code) — Standard Industrial Classification
FAQ
What specific amendments were made to the Articles of Incorporation or Bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text snippet.
What are the 'other events' reported in this 8-K?
The filing lists 'Other Events' as an item information, but the specific nature of these events is not detailed in the provided text.
What is the primary business of HELIUS MEDICAL TECHNOLOGIES, INC.?
HELIUS MEDICAL TECHNOLOGIES, INC. is in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, SIC code 3845.
When was the company incorporated?
The company was incorporated in Delaware.
What is the Commission File Number for HELIUS MEDICAL TECHNOLOGIES, INC.?
The Commission File Number is 001-38445.
Filing Stats: 807 words · 3 min read · ~3 pages · Grade level 10.8 · Accepted 2025-09-29 08:25:34
Key Financial Figures
- $0.001 — whichregistered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar
Filing Documents
- tm2527115d1_8k.htm (8-K) — 32KB
- tm2527115d1_ex3-1.htm (EX-3.1) — 8KB
- tm2527115d1_ex3-2.htm (EX-3.2) — 216KB
- tm2527115d1_ex99-1.htm (EX-99.1) — 13KB
- 0001104659-25-094134.txt ( ) — 482KB
- hsdt-20250929.xsd (EX-101.SCH) — 3KB
- hsdt-20250929_lab.xml (EX-101.LAB) — 33KB
- hsdt-20250929_pre.xml (EX-101.PRE) — 22KB
- tm2527115d1_8k_htm.xml (XML) — 4KB
03. Amendments to Articles of Incorporation or Bylaws
Item 5.03. Amendments to Articles of Incorporation or Bylaws Change in Fiscal Year. Change in Company Name On September 25, 2025, the Board of Directors (the "Board") of Helius Medical Technologies, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on July 18, 2018 (the "Certificate of Incorporation"), to change the Company's name to Solana Company (the "Name Change"). On September 26, 2025, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the "Certificate of Amendment") to the Certificate of Incorporation, which will effect the Name Change at 8:00 a.m. Eastern Time on September 29, 2025. Pursuant to Section 242(d)(1) of the General Corporation Law of the State of Delaware (the "DGCL"), the Name Change did not require approval of the Company's stockholders and will not affect the rights of the Company's security holders. A copy of the Certificate of Amendment is included as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein. Additionally, the Board approved an amendment to the Company's Second Amended and Restated Bylaws solely to reflect the Name Change (the "Third Amended and Restated Bylaws"). The Third Amended and Restated Bylaws will become effective immediately after the Name Change on September 29, 2025. In accordance with the DGCL and the provisions of the Company's organizational documents, the Board approved the Third Amended and Restated Bylaws, and stockholder approval was not required for such amendment. A copy of the Third Amended and Restated Bylaws is included as Exhibit 3.2 to this Current Report on Form 8-K and is incorporated by reference herein.
01. Other Events
Item 8.01. Other Events. Press Release On September 29, 2025, the Company issued a press release (the "Press Release") to announce the Name Change, as well as the Company's entry into a non-binding letter of intent with the Solana Foundation (the "Foundation") which sets forth the principal terms of HSDT's commitment to SOL, the Company's future partnership with the Foundation and certain purchase option rights granted to the Company. A copy of the Press Release is included as Exhibit 99.1 to this Current Report on Form 8-K. 2
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description of Exhibits 3.1 Certificate of Amendment to the Certificate of Incorporation of Helius Medical Technologies, Inc., as filed with the Secretary of State of the State of Delaware on September 26, 2025, and effective on September 29, 2025. 3.2 Third Amended and Restated Bylaws, effective September 29, 2025. 99.1 Press Release, issued September 29, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HELIUS MEDICAL TECHNOLOGIES, INC. Dated: September 29, 2025 By: /s/ Jeffrey S. Mathiesen Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary 4